Current and future uses of real-time polymerase chain reaction and microarrays in the study of intestinal microbiota, and probiotic use and effectiveness

Canadian Journal of Microbiology

Volumn 53, Issue 5, 2007, Pages 537-550

  Carey, Christine M ^a   Kirk, Jennifer L ^a   Ojha, Shivani ^a   Kostrzynska, Magdalena ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Lactic acid bacteria; Microarrays; Probiotics; Real time PCR

Indexed keywords

LACTIC-ACID BACTERIA; POLYMERASE CHAIN REACTION (PCR); POULTRY; PROBIOTICS; REAL-TIME PCR;

AGRICULTURE; BIOCHEMISTRY; DISEASE CONTROL; ECOSYSTEMS; GASTROENTEROLOGY; HEALTH CARE; MICROARRAYS; NUTRIENTS;

MICROORGANISMS;

1,4 DIHYDROXY 2 NAPHTHOIC ACID; ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL NO. 3;

BACTERIUM; DIARRHEAL DISEASE; DISEASE TREATMENT; GENOME; HEALTH MONITORING; LIVESTOCK FARMING; MICROBIAL COMMUNITY; NUTRITIONAL STATUS; POLYMERASE CHAIN REACTION; PROBIOTICS; PUBLIC HEALTH;

ACCURACY; ANTIBIOTIC RESISTANCE; AUTOIMMUNE DISEASE; BACTERIAL METABOLISM; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; DNA MICROARRAY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG STRUCTURE; ECOSYSTEM; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; HOST CELL; HUMAN; IN VIVO STUDY; INTESTINE FLORA; LACTIC ACID BACTERIUM; MICROBIAL GENETICS; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SPECIES CULTIVATION; SUSTAINED RELEASE PREPARATION;

ANIMALS; HUMANS; INTESTINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROBIOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 34547795116     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W07-039     Document Type: Review

References (85)

1. Adjiri-Awere, A., and Van Lunen, T.A. 2005. Subtherapeutic use of antibiotics in pork production: risks and alternatives. Can. J. Anim. Sci. 85: 117-130.
2. Azcarate-Peril, M.A., McAuliffe, O., Altermann, E., Lick, S., Russell, W.M., and Klaenhammer, T.R. 2005. Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus. Appl. Environ. Microbiol. 71: 5794-5804. doi:10.1128/AEM.71.10.5794-5804.2005.
3. Balsari, A., Ceccarelli, A., Dubini, F., Fesce, E., and Poli, G. 1982. The fecal microbial population in the irritable bowel syndrome. Microbiologica, 5: 185-194.
4. Bartosch, S., Fite, A., Macfarlane, G.T., and McMurdo, M.E.T. 2004. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitilized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microflora. Appl. Environ. Microbiol. 70: 3575-3581. doi:10.1128/AEM.70.6.3575-3581.2004.
5. Bartosch, S., Woodmansey, E.J., Paterson, J.C., McMurdo, M.E., and Macfarlane, G.T. 2005. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum. Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin. Infect. Dis. 40: 28-37. doi:10.1086/426027.
6. Boehm, G., Fanaro, S., Jelinek, J., Stahl, B., and Marini, A. 2003. Prebiotic concept for infant nutrition. Acta Paediatr. Suppl. 91 (Suppl.): 64-67.
7. Brigidi, P., Vitali, B., Swennen, E., Bazzocchi, G., and Matteuzzi, D. 2001. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res. Microbiol. 152: 735-741. doi:10.1016/S0923- 2508(01)01254-2.
8. Bustin, S.A. 2002. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29: 23-39. doi:10.1677/jme.0.0290023.
9. Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonata, V., Marzotti, S., et al. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia, 48: 1565-1575. doi:10.1007/s00125-005-1831- 2.
10. Cerniglia, C.E., and Kotarski, S. 1999. Evaluation of veterinary drug residue in food for their potential to affect human intestinal microflora. Regul. Toxicol. Pharmacol. 29: 238-261. doi:10.1006/rtph.1999.1300.
11. Delcenserie, V., Bechoux, N., China, B., Daube, G., and Gavini, F. 2005. A PCR method for detection of bifidobacteria in raw milk and raw milk cheese: comparison with culture-based methods. J. Microbiol. Methods, 61: 55-67. doi:10.1016/j.mimet.2004.11.001.
12. Di Caro, S., Tao, H., Grillo, A., Elia, C., Gasbarrini, G., Sepulveda, A.R., and Gasbarrini, A. 2005a. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig. Liver Dis. 37: 320-329.
13. Di Caro, S., Tao, H., Grillo, A., Franceschi, F., Elia, C., Zocco, M.A., et al. 2005b. Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur. J. Gastroenterol. Hepatol. 17: 951-960. doi:10.1097/00042737-200509000-00011.
14. Dixit, S., and Kailasapathy, K. 2005. Bacterial diversity of Escherichia coli in the gut: a reason to re-evaluate probiotic formulations. Curr. Issues Intest. Microbiol. 6: 17-24.
15. Dowd, S.E., and Ishizaki, H. 2006. Microarray based comparison of two Escherichia coli O157:H7 lineages. BMC Microbiol. 6: 30-36. doi:10.1186/1471-2180-6-30.
16. Drasar, B.S., and Roberts, A.K. 1990. Control of the large bowel microflora. CRC Press, Fla. pp 95-100.
17. Fuller, R. 1991. Probiotics in human medicine. Gut, 32: 439-442.
18. Gagnon, M., Kheadr, E.E., Le Blay, G., and Fliss, I. 2004. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. Int. J. Food Microbiol. 92: 69-78. doi:10.1016/j. ijfoodmicro.2003.07.010.
19. Garrigues, C., Stuer-Lauridsen, B., and Johansen, E. 2005. Characterization of Bifidobacterium animalis subsp. lactis BB-12 and other probiotic bacteria using genomics, transcriptomics and proteomics. Aust. J. Dairy Technol. 60: 84-92.
20. Gavini, F., Cayuela, C., Antoine, M.J., Lecoq, C., Levfebre, B., Membre, J.M., and Neut, C. 2001. Differences in the distribution of bifidobacterial and enterbacterial species in human fecal microflora of three different (children, adults, elderly) age groups. Micro. Ecol. in Health and Dis. 13: 40-45.
21. Grattepanche, F., Lacroix, C., Audet, P., and Lapointe, G. 2005. Quantification by real-time PCR of Lactococcus lactis subsp. cremoris in milk fermented by a mixed culture. Appl. Microbiol. Biotechnol. 99: 414-421.
22. Guarner, F., and Schaafsma, G.J. 1998. Probiotics. Int. J. Food Microbiol. 39: 237-238. doi:10.1016/S0168-1605(97)00136-0.
23. Gueimonde, M., Tölkkö, S., Korpimäki, T., and Salminen, S. 2004. New real-time quantitative PCR procedure for quantification of Bifidobacteria in human fecal samples. Appl. Environ. Microbiol. 70: 4165-4169. doi:10.1128/AEM.70.7.4165-4169.2004.
24. Haarman, M., and Knol, J. 2005. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 71: 2318-2324. doi:10.1128/AEM.71.5.2318-2324.2005.
25. Haarman, M., and Knol, J. 2006. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 72: 2359-2365. doi:10.1128/AEM.72.4. 2359-2365.2006.
26. Hanna, S.E., Connor, C.J., and Wang, H.H. 2005. Real-time polymerase chain reaction for the food microbiologist: technologies, applications, and limitations. J. Food Sci. 70: R49-R53.
27. Heselmans, M., Reid, G., Akkermans, L.M., Savelkoul, H., Timmerman, H., and Rombouts, F.M. 2005. Gut flora in health and disease: potential role of probiotics. Curr. Issues Intest. Microbiol. 6: 1-7.
28. Heyman, M., and Menard, A. 2002. Probiotic microorganisms: how they affect intestinal pathophysiology. Cell. Mol. Life Sci. 59: 1151-1165.
29. Hooper, L.V., Wong, M.H., Thelin, A., Hanson, I., Falk, P.G., and Gordon, J.I. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science (Washington, D.C.), 291: 881-884. doi:10.1126/science. 291.5505.881.
30. Hopkins, M.J., and Macfarlane, G.T. 2002. Changes in predominant bacterial populations in human feces with age and with Clostridium difficile infection. J. Med. Microbiol. 51: 448-454.
31. Ishibashi, N., and Yamazaki, S. 2001. Probiotics and safety. Am. J. Clin. Nutr. 73: 465s-470s.
32. Isolauri, E., Kirjavainen, P.V., and Salminen, S. 2002. Probiotics: A role in the treatment of intestinal infection and inflammation? Gut, 50: iii54-iii59.
33. Ji, G., Beavis, R., and Novick, R.P. 1997. Bacterial interference caused by autoinducing peptide variants. Science (Washington, D.C.), 276: 2027-2030. doi:10.1126/science.276.5321.2027.
34. Kastner, S., Perreten, V., Bleuler, H., Hugenschmidt, G., Lacroix, C., and Meile, L. 2006. Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food. Syst. Appl. Microbiol. 29: 145-155. doi:10.1016/j.syapm.2005.07.009.
35. Konstantinov, S.R., Smidt, H., and de Vos, W.M. 2005. Representational difference analysis and real-time PCR for strain-specific quantification of Lactobacillus sobrius sp. nov. Appl. Environ. Microbiol. 71: 7578-7581. doi:10.1128/AEM.71.11.7578-7581. 2005.
36. Kostrzynska, M., and Bachand, A. 2006. Application of DNA microarray technology for detection, identification, and characterization of food-borne pathogens. Can. J. Microbiol. 52: 1-8. doi:10.1139/w05-105.
37. Lan, Y., Xun, S., Tamminga, S., Williams, B.A., Verstegen, M.W., and Erdi, G. 2004. Real-time PCR detection of lactic acid bacteria in cecal contents of Eimeria tenella-infected broilers fed soybean oligosaccharides and soluble soybean polysaccharides. Poult. Sci. 83: 1696-1702.
38. Lemarchand, K., Masson, L., and Brousseau, R. 2004. Molecular biology and DNA microarray technology for microbial quality monitoring of water. Crit. Rev. Microbiol. 30: 145-172. doi:10.1080/10408410490435142.
39. Li, J., Pankratz, M., and Johnson, J.A. 2002. Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. Toxicol. Sci. 69: 383-390. doi:10.1093/toxsci/69.2.383.
40. Lipp, M., Bluth, A., Eyquem, F., Kruse, L., Schimmel, H., and Van den Eed, G. 2001. Validation of a method based on polymerase chain reaction for the detection of genetically modified organism in various processed foodstuff. Eur. Food Res. Technol. 212: 497-504. doi:10.1007/s002170000274.
41. Liu-Stratton, Y., Roy, S., and Sen, C.K. 2004. DNA microarray technology in nutraceutical and food safety. Toxicol. Lett. 150: 29-42. doi:10.1016/j.toxlet.2003.08.009.
42. Mackay, I.M. 2004. Real-time PCR in the microbiology laboratory. Clin. Microbiol. Infect. 10: 190-212. doi:10.1111/j.1198-743X.2004.00722.x.
43. Malinen, E., Rinttilä, T., Kajander, K., Mättö, J., Kassinen, A., Krogius, L., et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100: 373-382. doi:10.1111/j.1572-0241.2005.40312.x.
44. Matsuki, T., Watanabe, K., and Tanaka, R. 2003. Genus- and species-specific PCR primers for the detection and indentification of bifidobacteria. Curr. Issues Intest. Microbiol. 4: 61-69.
45. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K, and Tanaka, R. 2004. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal Bifidobacteria. Appl. Environ. Microbiol. 70: 167-173. doi:10.1128/AEM.70.1.167-173. 2004.
46. Montesi, A., Garcia-Albiach, R., Pozuelo, M.J., Pintado, C., Goni, I., and Rotger, R. 2005. Molecular and microbiological analysis of caecal microbiota in rats fed with diets supplemented either with prebiotics or probiotics. Int. J. Food Microbiol. 98: 281-290. doi:10.1016/j.ijfoodmicro.2004.06.005.
47. Moore, W.E.C., and Moore, L.H. 1995. Intestinal floras of populations that have a high risk of colon cancer. Appl. Environ. Microbiol. 61: 3202-3207.
48. Nobaek, S., Johansson, M.L., Molin, G., Ahrnes, S., and Jeppsson, B. 2000. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 95: 1231-1238. doi:10.1111/j.1572-0241.2000.02015.x.
49. Okada, Y., Tsuzuki, Y., Miyazaki, J., Hokari, R., Komoto, S., Kato, S., et al. 2005. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates DSS-induced colitis by modulation of bacterial flora and lymphocyte homing. Gut, 55: 681-688.
50. Pena, J.A., Rogers, A.B., Ge, Z., Ng, V., Li, S.Y., Fox, J.G., and Versalovic, J. 2005. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect. Immun. 73: 912-920. doi:10.1128/IAI.73.2.912-920.2005.
51. Penders, J., Vink, C., Driessen, C., London, N., Thijs, C., and Stobberingh, E.E. 2005. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in fecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol. Lett. 243: 141-147. doi:10.1016/j.femsle.2004.11.052.
52. Perreten, V., Vorlet-Fawer, L., Slickers, P., Ehricht, R., Kuhnert, P., and Frey, J. 2005. Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. J. Clin. Microbiol. 43: 2291-2302. doi:10.1128/JCM.43.5.2291-2302.2005.
53. Requena, T., Burton, J., Matsuki, T., Munro, K., Simon, M.A., Tanaka, R., Watanabe, K., and Tannock, G.W. 2002. Identification, detection, and enumeration of human Bifidobacterium species by PCR-targeting the transaldolase gene. Appl. Environ. Microbiol. 68: 2420-2427. doi:10.1128/AEM.68.5.2420-2427.2002.
54. Rinttilä, T., Kassinen, A., Malinen, E., Krogius, L., and Palva, A. 2004. Development of an extensive set of 16S rDNA-target primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 97: 1166-1177. doi:10.1111/j.1365- 2672.2004.02409.x.
55. Rochet, V., Rigottier-Gois, L., Sutren, M., Krementscki, M.N., Andrieux, C., Furet, J.P., et al. 2006. Effects of orally administered Lactobacillus casei DN-114001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br. J. Nutr. 95: 421-429. doi:10.1079/BJN20051625.
56. Rudi, K, Moen, B., Dromtorp, S.M., and Hoick, A.L. 2005. Use if ethidium monoazide and PCR in combination for quantification of viable and dead cells in complex samples. Appl. Environ. Microbiol. 71: 1018-1024. doi:10.1128/AEM.71.2.1018-1024.2005.
57. Saito, Y., Sakamoto, M., Takizawa, S., and Benno, Y. 2004. Monitoring the cell number and viability of Lactobacillus helveticus GCL1001 in human feces by PCR methods. FEMS Microbiol. Lett. 231: 125-130. doi:10.1016/S0378-1097(03)00951-0.
58. Sanders, M.E., and Klaenhammer, T.R. 2001. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J. Dairy Sci. 84: 319-331.
59. Sauter, S.N., Allenspach, K., Gaschen, F., Gröne, A., Ontsouka, E., and Blum, J.W. 2005. Cytokine expression in an ex vivo culture system of duodenal samples from dogs with chronic enteropathies: modulation by probiotic bacteria. Domest. Anim. Endocrinol. 29: 605-622. doi:10.1016/j.domaniend. 2005.04.006.
60. Schultz, M., Munro, K., Tannock, G.W., Melchner, I., Gottl, C., Schwietz, H., Scholmerich, J., and Rath, H.C. 2004. Effects of feeding probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora HLA-B27 transgenic rats. Clin. Diagn. Lab. Immunol. 11: 581-587. doi:10.1128/CDLI.11.3.581-587.2004.
61. Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Martean, P., Jian, R., and Doré, J. 2003. Alterations of the dominant fecal bacteria groups in patients with Crohn's disease of the colon. Gut, 52: 237-242. doi:10.1136/gut.52.2.237.
62. Selim, A.S., Boonkumklao, P., Sone, T., Assavanig, A., Wada, M., and Yokota, A. 2005. Development and assessment of a real-time PCR assay for rapid and sensitive detection of a novel thermotolerant bacterium, Lactobacillus thermotolerans, in chicken feces. Appl. Environ. Microbiol. 71: 4214-4219. doi:10.1128/AEM.71.8.4214-4219.2005.
63. Sepulveda, A.R., Tao, J., Carloni, E., Sepulveda, J., Graham, D.Y., and Peterson, L.E. 2002. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment. Pharmacol. Ther. 16: 145-157. doi:10.1046/j.1365-2036.16.s2.4.x.
64. Sergeev, N., Distler, M., Vargas, M., Chizhikov, V., Herold, K.E., and Rasooly, A. 2006. Microarray analysis of Bacillus cereus group virulence factors. J. Microbiol. Methods, 65: 488-502.
65. Shimosato, T., Kitazawa, H., Katoh, S., Tohno, M., Iliev, I.D., Nagasawa, C., et al. 2005. Augmentation of TH-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling. Biochem. Biophys. Res. Commun. 326: 782-787. doi:10.1016/j.bbrc.2004.11. 119.
66. Shippy, R., Sendera, T.J., Lockner, R., Palaniappan, C., Kaysser-Kranich, T., Watts, G., and Alsobrook, J. 2004. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise making cross-platform correlations. BMC Genomics. 5: 61. doi:10.1186/1471-2164-5-61.
67. Stefano, G.B., Burrill, J.D., Labur, S., Blake, J., and Cadet, P. 2005. Regulation of various genes in human leukocytes acutely exposed to morphine: expression microarray analysis. Med. Sci. Monit. 11: MS35-MS42.
68. Sturme, M.H.J., Nakayama, J., Molenaar, D., Murakami, Y., Kunugi, R., Fujii, T., et al. 2005. An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence. J. Bacteriol. 187: 5227-5235.
69. Sullivan, A., Edlund, C., and Nord, C.E. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1: 101-114.
70. Talwalkar, A., and Kailasapathy, K. 2004. The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp. Curr. Issues Intest. Microbiol. 5: 1-8.
71. Tan, P.K., Downey, T.J., Spitznagel, E.L.J., Xu, P., Fu, D., Dimitrov, D.S., et al. 2003. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 31: 5676-5684. doi:10.1093/nar/gkg763.
72. Tannock, G.W. 2002. Probiotics and prebiotics: Where are we going? Caister Academic Press, London, pp 1-39.
73. Tao, Y., Drabik, K.A., Waypa, T.S., Musch, M.W., Alverdy, J.C., Schneewind, O., Chang, E.B., and Petrof, E.O. 2006. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am. J. Physiol. Cell. Physiol. 290: C1018-C1030.
74. Tien, M.T., Girardin, S.E., Regnault, B., Le Bourhis, L., Dillies, M.A., Coppée, J.Y., et al. 2006. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176: 1228-1237.
75. Ukena, S.N., Westendorf, A.M., Hansen, W., Rohde, M., Geffers, R., Coldewey, S., et al. 2005. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med. Genet. 6: 43-56. doi:10.1186/1471-2350-6-43.
76. Ventura, M., van Sinderen, D., Fitzgerald, G.F., and Zink, R. 2004. Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie Van Leeuwenhoek. 86: 205-223. doi:10.1023/B:ANTO.0000047930.11029.ec.
77. Vitali, B., Candela, M., Matteuzzi, D., and Brigidi, P. 2003. Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR. Syst. Appl. Microbiol. 26: 269-276. doi:10.1078/072320203322346128.
78. Wang, R.F., Beggs, M.L., Robertson, L.H., and Cerniglia, C.E. 2002a. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacterial in fecal samples. FEMS Microbiol. Lett. 213: 175-182. doi:10.1111/j.1574-6968.2002.tb11302.x.
79. Wang, R.F., Kim, S.J., Robertson, L.H., and Cerniglia, C.E. 2002b. Development of a membrane-array method for the detection of human intestinal bacteria in fecal samples. Mol. Cell. Probes, 16: 341-350. doi:10.1006/mcpr.2002.0432.
80. Wang, R.F., Beggs, M.L., Erickson, B.D., and Cerniglia, C.E. 2004. DNA microarray analysis of predominant human intestinal bacteria in fecal samples. Mol. Cell. Probes, 18: 223-234. doi:10.1016/j.mcp.2004.03.002.
81. Wang, Y., Barbacioru, C., Hyland, F., Xiao, W., Hunkapiller, K.L., Blake, J., et al. 2006. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics. 7: 59-75. doi:10.1186/1471-2164-7-59.
82. Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T., Tajiri, Y., and Kumemura, M. 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 111: 587-591. doi:10.1067/mai.2003.105.
83. Wong, M.L., and Medrano, J.F. 2005. Real-time PCR for mRNA quantitation. Biotechniques, 39: 75-85.
84. Yang, D.K., Kweon, C.H., Kim, B.H., Lim, S.L., Kim, S.H., Kwon, J.H., and Han, H.R. 2004. TaqMan reverse transcription polymerase chain reaction for the detection of Japanese encephalitis virus. J. Vet. Sci. 5: 345-351.
85. Zhao, J.R., Bai, Y.J., Zhang, Q.H., Wan, Y., Li, D., and Yan, X.J. 2005. Detection of hepatitis B virus DNA by real-time PCR using TaqMan-MGB probe technology. World J. Gastroenterol. 11: 508-510.